Kinnate Biopharma (NASDAQ:KNTE) develops small molecule kinase inhibitors to treat genomically defined cancers. The company has two molecules in the clinic, exarafenib and KIN-3248....
Having a good investment philosophy matters as much as picking the “right” stocks. That’s because even dominant companies can fall on hard times due...
(Reuters) – Alberta authorities hope cooler temperatures and showers forecast for the coming week will help firefighters battling blazes in the oil-rich Canadian province,...